Paeds · endocrinology-diabetes-and-growth
Tall stature and overgrowth syndromes
Also known as tall stature · overgrowth syndrome · gigantism · Sotos syndrome · Beckwith-Wiedemann syndrome · Weaver syndrome · familial tall stature
A fellowship approach to the tall child: separate the familial and constitutional normal variants from the pathological causes — syndromic overgrowth (Sotos, Beckwith-Wiedemann, Weaver, Simpson-Golabi-Behmel, Tatton-Brown-Rahman), growth-hormone excess, and chromosomal or hormonal delay — using a structured dysmorphology and proportion assessment, targeted genetic testing, and syndrome-specific tumour surveillance.
On this page
Study tools
Your progress
Saved on this device.
Practise this topic
Target exams
Red flags
- An infant with macrosomia, macroglossia, and an umbilical defect is Beckwith-Wiedemann spectrum until the 11p15 imprinting is mapped, because the tumour surveillance that follows saves lives
- Coarse facial features with enlarging hands, feet, and jaw in a growing child is growth-hormone excess — send IGF-1 before the bones fuse
- A tall child with intellectual disability, advanced bone age, and a characteristic facial gestalt has a syndromic overgrowth disorder, not familial tall stature
- Hemihyperplasia or asymmetry in an overgrown infant carries a Wilms tumour and hepatoblastoma risk that demands abdominal ultrasound every three months to age eight
- A marfanoid habitus with arm span exceeding height demands echocardiography for the aortic root, because aortic dissection is the preventable killer
- Precocious puberty makes a child tall now but short at final height, because early oestrogen fuses the epiphyses early — recognise and treat before the window closes
Life stages
Care settings
Clinical exam formats
Board mappings
- General and Community Paediatrics
- Growth and Development
- Genetics and metabolic medicine
- Endocrinology and growth - evaluate tall stature and recognise overgrowth syndromes
- Genetics and metabolic medicine - recognise, investigate and manage overgrowth syndromes with tumour risk
- Renewed curriculum for first-year trainees from 2027 - Learning goal 6: Clinical management - essential general paediatrics
- Endocrinology 10-12
- Growth and Development 10-12
- Clinical Applications
- Long Cases
- Short Cases
- 10. Genetics - Chromosomal and gene disorders including overgrowth syndromes
- 1. Endocrinology: growth disorders
- 4. Professional skills and knowledge: Patient management
- Foundation of Practice (FOP)
- Theory and Science (TAS)
- Applied Knowledge in Practice (AKP)
- Clinical
- History
- Communication
- Video
- General Pediatrics Content Outline - D18 Endocrinology (3%)
- General Pediatrics Content Outline - D21 Genetics/Dysmorphology/Metabolic (2%)
- General Pediatrics Content Outline - Universal Task 4: Management and Treatment
- Patient Care 4: Clinical Reasoning
- Patient Care 5: Patient Management
- Medical Knowledge 1: Congenital anomalies and genetics
- Systems-Based Practice 1: Patient Safety
- Medical Expert
- Pediatrics: Foundations EPA #8 - Communicating assessment findings and management plans to patients and/or families
- Pediatrics: Endocrinology and Growth applied domain
Use OVER-GROW to decide whether a tall child is a normal variant or needs testing: Organomegaly or macrosomia (Beckwith-Wiedemann), Velocity crossing centiles upward (pathological), Eunuchoid proportions — span exceeding height (Klinefelter, delayed puberty), Redistribution — dysmorphism, asymmetry, macrocephaly (syndromic), Genital or pubertal abnormality (precocious or absent), Reason — intellectual disability or developmental concern (syndromic overgrowth), Origin — no tall parents to explain it. Any one redistributes the child from "just tall" to "investigate now". [6] [10]
Overview & Definition
Tall stature is the mirror image of short stature in statistical terms — a height lying more than two standard deviations above the age- and sex-specific mean — but its clinical meaning is almost the opposite. Where short stature almost always earns an investigation, tall stature usually earns reassurance, because the great majority of tall children are healthy and reflect the genetic endowment of their parents. The skill is therefore not in detecting the tall child but in redistributing the few who carry a pathological cause out of the reassuring majority, and the redistribution rests on a structured assessment rather than on the height number alone. [6]
Familial tall stature is the commonest single cause. A child whose parents are both tall has a high mid-parental target height, grows at a normal velocity along a high centile, has a normal physical examination and body proportions, and a bone age that matches the chronological age. Constitutional advancement of growth is a closely related variant in which an early, self-limited growth spurt and slightly advanced bone age produce a child who is tall relative to peers in mid-childhood but reaches a final adult height within the normal range. Neither of these variants carries intellectual disability, dysmorphism, or tumour risk, and the clinical task is to document the evidence that confirms the variant rather than to investigate reflexively. [7]
The pathological causes demand a different posture, because each carries a consequence that reassurance would delay. Syndromic overgrowth disorders — Sotos, Beckwith-Wiedemann, Weaver, Simpson-Golabi-Behmel, and the Tatton-Brown-Rahman and related methylation-disorder family — pair excess growth with intellectual disability and, in several, a defined embryonal tumour risk. Growth-hormone excess produces gigantism in the open-epiphysis child and carries the cardiovascular and mass consequences of a pituitary adenoma. Chromosomal and hormonal causes, from Klinefelter syndrome to precocious puberty, reshape the growth trajectory and the final height, and several are treatable. The general paediatrician sits at the gate, deciding who is reassured and who is referred. [8] [4]
References12ShowHide
- [1]Ocansey S, Cole TRP, Rahman N, et al. Sotos Syndrome. GeneReviews, 1993.PMID 20301652
- [2]Brioude F, Kalish JM, Mussa A, et al. Expert consensus document: Clinical and molecular diagnosis, screening and management of Beckwith-Wiedemann syndrome. Nat Rev Endocrinol, 2018.PMID 29377879
- [3]Gibson WT, Hood RL, Zhan SH, et al. Mutations in EZH2 cause Weaver syndrome. Am J Hum Genet, 2012.PMID 22177091
- [4]Lui JC, Baron J. Epigenetic Causes of Overgrowth Syndromes. J Clin Endocrinol Metab, 2024.PMID 37450557
- [5]Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB, Hilhorst-Hofstee Y, Jondeau G, Faivre L, Milewicz DM, Pyeritz RE, Sponseller PD, Wordsworth P, De Paepe AM. The revised Ghent nosology for the Marfan syndrome. J Med Genet, 2010.PMID 20591885
- [6]Caro R, Savel P, Moss PI. Evaluation of Short and Tall Stature in Children. Am Fam Physician, 2025.PMID 40531152
- [7]Sada V, Puliani G, Feola T, et al. Tall stature and gigantism in transition age: clinical and genetic aspects-a literature review. J Endocrinol Invest, 2024.PMID 37891382
- [8]Tatton-Brown K, Loveday C, Yost S, Clarke M, Ramsay E, Zachariou A, Elliott A, Wylie H, Ardissone A, Rittinger O, Stewart F, Temple IK, Cole T; Childhood Overgrowth Consortium, Mahamdallie S, Seal S, Ruark E, Rahman N. Mutations in Epigenetic Regulation Genes Are a Major Cause of Overgrowth with Intellectual Disability. Am J Hum Genet, 2017.PMID 28475857
- [9]Maas SM, Vansenne F, Kadouch DJ, Ibrahim A, Bliek J, Hopman S, Mannens MM, Merks JH, Maher ER, Hennekam RC. Phenotype, cancer risk, and surveillance in Beckwith-Wiedemann syndrome depending on molecular genetic subgroups. Am J Med Genet A, 2016.PMID 27419809
- [10]Argente J, Tatton-Brown K, Lehwalder D, Pfäffle R. Genetics of Growth Disorders-Which Patients Require Genetic Testing? Front Endocrinol (Lausanne), 2019.PMID 31555216
- [11]Shen W, Heeley JM, Carlston CM, et al. The spectrum of DNMT3A variants in Tatton-Brown-Rahman syndrome overlaps with that in hematologic malignancies. Am J Med Genet A, 2017.PMID 28941052
- [12]Russo S, Milani D, Meossi C, et al. Beckwith-Wiedemann spectrum (BWSp): an update on diagnosis, management, and follow-up from the Italian BWSp Register. Ital J Pediatr, 2025.PMID 41126215